BMJ  2007;334:1079 (26 May), doi:10.1136/bmj.39220.694109.DB

News

Research ethics have not "sunk to an all time low"

Geoff Watts

London

The first 150 words of the full text of this article appear below.

Clinical researchers working on new drugs were "cleared" last week of allowing their ethical standards to sink to an all time low, in a debate held at a conference on clinical research at the Royal College of Physicians in London.

A small majority of the audience worked in the drug industry, and although the debate was not limited to research within the industry the convincing win must have cheered those in the drug business, who feel that they have recently been under attack.

The contestants in the debate, entitled "This house believes that the ethics of clinical research have reached an all time low," were Richard Smith, former editor of the BMJ and now executive director at UnitedHealth Europe, who argued for the motion, and Trevor Jones, former director general of the Association of the British Pharmaceutical Industry.

Dr Smith's first example of unethical behaviour by researchers inside and outside . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Severe adverse reactions prompt call for trial design changes
Susan Mayor
BMJ 2006 332: 683. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ